ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma

Journal of Clinical Neuroscience

Volumn 19, Issue 12, 2012, Pages 1700-1705

  Liu, Ding Yang ^a   Ren, Cai Ping ^b   Yuan, Xian Rui ^a   Zhang, Li Hua ^b   Liu, Jie ^b   Liu, Qing ^a   Yuan, Jian ^a   Yuan, Dun ^a   Jiang, Xing Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ALDH1; Astrocytoma; Prognosis; Tumor stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETINAL DEHYDROGENASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84868303670     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.01.036     Document Type: Article

References (26)

1. A.K. Nowak, J.E. Maujean, and M. Jackson A prospective study of surgical patterns of care for high grade glioma in the current era of multimodality therapy J Clin Neurosci 18 2011 227 231
2. A.B. Francesconi, S. Dupre, and M. Matos Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme J Clin Neurosci 17 2010 970 974
3. H. Ohgaki, and P. Kleihues Epidemiology and etiology of gliomas Acta Neuropathol 109 2005 93 108
4. S.S. Stylli, M. Howes, and L. MacGregor Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome J Clin Neurosci 11 2004 584 596
5. S.S. Stylli, A.H. Kaye, and L. MacGregor Photodynamic therapy of high grade glioma - long term survival J Clin Neurosci 12 2005 389 398
6. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies J Clin Neurosci 13 2006 709 717
7. T. Reya, S.J. Morrison, and M.F. Clarke Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
8. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
9. P.C. Hermann, S. Bhaskar, and M. Cioffi Cancer stem cells in solid tumors Semin Cancer Biol 20 2010 77 84
10. S.K. Singh, I.D. Clarke, and M. Terasaki Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821 5828
11. R. Pallini, L. Ricci-Vitiani, and G.L. Banna Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme Clin Cancer Res 14 2008 8205 8212
12. F. Zeppernick, R. Ahmadi, and B. Campos Stem cell marker CD133 affects clinical outcome in glioma patients Clin Cancer Res 14 2008 123 129
13. Y.H. Ma, R. Mentlein, and F. Knerlich Expression of stem cell markers in human astrocytomas of different WHO grades J Neurooncol 86 2008 31 45
14. Z. Huang, L. Cheng, and O.A. Guryanova Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting Protein Cell 1 2010 638 655
15. D.R. Laks, K. Visnyei, and H.I. Kornblum Brain tumor stem cells as therapeutic targets in models of glioma Yonsei Med J 51 2010 633 640
16. M. Patel, L. Lu, and D.S. Zander ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors Lung Cancer 59 2008 340 349
17. F. Jiang, Q. Qiu, and A. Khanna Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer Mol Cancer Res 7 2009 330 338
18. A.K. Croker, D. Goodale, and J. Chu High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J Cell Mol Med 13 2009 2236 2252
19. Y. Su, Q. Qiu, and X. Zhang Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer Cancer Epidemiol Biomarkers Prev 19 2010 327 337
20. M. Rasper, A. Schafer, and G. Piontek Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity Neuro Oncol 12 2010 1024 1033
21. E.H. Huang, M.J. Hynes, and T. Zhang Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res 69 2009 3382 3389
22. O. Awad, J.T. Yustein, and P. Shah High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition PLoS ONE 5 2010 e13943
23. M.R. Clay, M. Tabor, and J.H. Owen Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase Head Neck 32 2010 1195 1201
24. T. Tanei, K. Morimoto, and K. Shimazu Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers Clin Cancer Res 15 2009 4234 4241
25. A. Quinones-Hinojosa, N. Sanai, and M. Soriano-Navarro Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells J Comp Neurol 494 2006 415 434
26. K. Barami, A.E. Sloan, and A. Rojiani Relationship of gliomas to the ventricular walls J Clin Neurosci 16 2009 195 201